Instil Bio, Inc. (TIL) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US45783C2008

Price
6.83 USD
Market cap
45.51 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Instil Bio, Inc. financials

Fiscal year2025
Operating income-78.58 m USD
EBIT-65.54 m USD
Net income-71.37 m USD
Diluted EPS – continuing operations-10.70 USD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Instil Bio, Inc.

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.